Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Innovation and Technology Payment (ITP) 2019/20 program began on April 1, 2019

The NHS Innovation and Technology Payment (ITP) 2019/20 program went live on April 1, 2019, and builds on the Innovation and Technology Tariff (ITT) and ITP 2018/19.

The ITP aims to remove barriers to the spread and adoption of innovative products or technologies (medical devices, digital platforms, and technologies), including financial negotiations. The program forms part of a more extensive set of activities to support innovation in the NHS, led by NHS England.

To be selected for the ITP, products needed to meet the following criteria:

  • NICE support (through a Medtech Innovation Briefing or Guidance)
  • Positive in-year return on investment
  • Use in at least three NHS organizations

These criteria focus the ITP on proven innovations within-year return on investment that are ready for national adoption. For this year, the following topics are being supported from April 1, 2019:

  • Non-invasive vagus nerve stimulation therapy for the treatment of cluster headaches
  • Absorbable spacer to reduce rectum radiation exposure during prostate radiation therapy
  • Placental growth factor (PIGF) based test for the rule‑out of preeclampsia
  • High sensitivity troponin assay in a rapid rule-out a protocol for acute myocardial infarction

Additionally, two topics will be supported by the Evidence Generation Fund. These topics will have a more limited roll-out with more intensive evaluation support:

  • Digital apps to support emergency/crisis mental health assessments
  • Interoperable personal health record tool

About the program:

  • The Innovation and Technology Payment (ITP) 2019/20 builds on the Innovation and Technology Tariff (ITT) and ITP 2018/19. It supports the NHS in adopting innovation by removing some of the financial or procurement barriers which can inhibit uptake at scale
  • It is a competitive process designed to scale up the adoption of innovations and technologies that have already proved their clinical effectiveness and are ready for nationwide spread
  • The ITP’s focus is to support a range of cost-effective medical devices, digital platforms, and technologies within our budgetary confines and will have a wide-reaching impact on patient care, deliver savings to the NHS and maximize learning from the program while fostering culture change
  • The ITP program forms part of a more comprehensive set of activities to support innovation in the NHS, led by NHS England and delivered with the support of the Academic Health Science Network
  • The implementation of any agreed payment mechanism or procurement is operational from  April 1, 2019
  • Day-to-day support and reporting will be via NHS England’s Innovation, Research, and Life Sciences Unit

The Innovation Technology Tariff of 2017/18 and the Innovation Technology Payment 2018/19 will continue to be supported during 2019/20. Details of these innovations can be found in the technical notes posted on this page during June 2019.

See full details in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.